ABIQUIFI - Associação Brasileira da Indústria de Insumos Farmacêuticos

What ABIQUIFI - Associação Brasileira da Indústria de Insumos Farmacêuticos does

ABIQUIFI (Associação Brasileira da Indústria de Insumos Farmacêuticos), founded in 1983 and headquartered in São Paulo's Berrini business district, is a non-profit industry association that exclusively represents Brazilian pharmaceutical input companies, including producers of Active Pharmaceutical Ingredients (APIs) — synthetic, botanical, and biotechnological — as well as raw material producers, CDMOs/CROs, and adjuvant manufacturers. The association functions as the sector's institutional representative before federal, state, and municipal government bodies, providing regulatory advocacy (notably on ANVISA frameworks and the new cannabis medicinal regulation), policy influence (co-shaping the R$ 600 million National Program for Radical Innovation in Health), and ecosystem coordination with research institutions including Fiocruz, Instituto Butantan, and CNPEM. Revenue is generated through non-disclosed annual membership fees paid by enterprise members such as EMS, Eurofarma, Cristália, Biolab, Bionovis, Blanver, Dechra, and others, supplemented by project partnerships with ApexBrasil.

ABIQUIFI's service portfolio spans institutional representation, the Brazilian Pharma & Health (BPH) internationalization project (organized trade missions and Brazilian Pavilions at BIO International Convention and CPHI Worldwide), the Dictionary of Pharmaceutical Substances digital reference, the Business Intelligence Comex trade analytics platform, the bioBR Magazine publication, professional training courses on API R&D and pharmaceutical pricing, the annual WNTC (We Need to Talk about Cannabis) conference co-organized with FCE Pharma, and innovation support services including a Cannabis Inputs Working Group. The association has no proprietary technology products and operates as a non-profit governed by a Board of Directors (President: Peter Martin Andersen of Centroflora Group; Vice-President: José Correia da Silva of Formil Química), three Advisors, and a three-member Fiscal Council representing diverse member companies.

Name

ABIQUIFI - Associação Brasileira da Indústria de Insumos Farmacêuticos

Legal name

ABIQUIFI - Associação Brasileira da Indústria de Insumos Farmacêuticos

Website

https://abiquifi.org.br

Company type

Private

Founded year

1983

Operating status

Operating

Headcount range

1–10 employees

Short description

ABIQUIFI is a non-profit industry association founded in 1983 in São Paulo that exclusively represents Brazilian pharmaceutical input manufacturers, providing regulatory advocacy, export promotion via the ApexBrasil-backed Brazilian Pharma & Health project, sectoral data and training, and ecosystem coordination across APIs, CDMOs, and research institutions.

Ownership category

akta.pro rank

Headquarters

HQ city

São Paulo

HQ country

Brazil

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Others

Revenue model

1. Membership Fees: Abiquifi is a non-profit association funded primarily through annual membership fees paid by pharmaceutical input companies, raw material producers, service providers, and adjuvant manufacturers operating in Brazil.

Go-to-market motion1 record

Distribution channels5 records

Marketing channels12 records

Core offering

ABIQUIFI is a Brazilian non-profit industry association that represents and advocates for the pharmaceutical inputs (active pharmaceutical ingredients) industry in Brazil. It provides collective representation, regulatory advocacy, technical training, export promotion support, and industry events for its member companies that manufacture pharmaceutical inputs. Founded in 1983, it serves as the principal industry voice on policy, trade, and regulatory matters affecting the sector.

Product overview

ABIQUIFI is a non-profit industry association founded in 1983 representing Brazilian pharmaceutical input industries. The organization does not offer a unified software product but provides a portfolio of services including the Brazilian Pharma & Health (BPH) export promotion program, the Dictionary of Pharmaceutical Substances reference resource, Business Intelligence Comex analytics, bioBR Magazine publication, professional courses and training, the annual WNTC cannabis conference, institutional advocacy, and innovation support services. These offerings work together to strengthen national production, promote internationalization, and advance innovation in Brazil's pharmaceutical input sector.

Differentiator

Problem solved

Functional benefit

Products and services

• Industry Advocacy and Regulatory Representation Collective representation of Brazilian pharmaceutical input manufacturers before regulatory agencies (notably ANVISA), government policymakers, and trade bodies. The service addresses the need for a unified industry voice on pharmaceutical regulation, trade policy, and industrial competitiveness. Targeted at member companies in the API manufacturing sector.
• Technical Training and Professional Development Training programs and professional development activities for personnel of pharmaceutical input manufacturing companies, covering regulatory compliance, manufacturing best practices, and industry-specific technical topics. Targeted at employees of member companies in the API sector.
• Export Promotion Services Programs and initiatives designed to support Brazilian pharmaceutical input manufacturers in developing international markets and growing exports of APIs and pharmaceutical inputs. Targeted at member companies seeking to expand beyond the domestic Brazilian market.
• Industry Events and Conferences Industry conferences, seminars, and trade events that convene Brazilian pharmaceutical input manufacturers, regulators, and international partners. These events facilitate networking, knowledge sharing, and collective discussion of sector issues. Targeted at member companies, regulators, and industry stakeholders.

Quantifiable outcome

• Brazil has 49 approved cannabis-based products and the first sanitary authorization involving a domestically produced cannabis API — a historic milestone for the sector.
• +6 more outcomes

Named customers23 records

Segments4 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

16 partnerships are on record, tiered core and minor.

• MDIC (Ministério do Desenvolvimento, Indústria, Comércio e Serviços)coreStrategic or Co-development Partner · 26 June 2026Abiquifi participated in the Conexões Produtivas event promoted by MDIC, ApexBrasil, and ABDI, connecting Brazilian companies to new business opportunities from the Mercosur-EU agreement. The event presented the Mercosul-EU Opportunity Study developed by ApexBrasil and discussed European market trends.
• FCE PharmacoreStrategic or Co-development Partner · 1 June 2026Abiquifi and FCE Pharma co-organize the WNTC (We Need to Talk about Cannabis) event, now in its 6th edition. The event brings together regulators, government, science, and industry to discuss the medicinal cannabis agenda in Brazil.
• GECEIS (Grupo Executivo do Complexo Econômico-Industrial da Saúde)coreStrategic or Co-development Partner · 24 November 2025Abiquifi supports the consolidation of the Health Economic-Industrial Complex (CEIS), a coordinated policy between federal government, scientific institutions, regulatory bodies, and the productive sector. R$ 1.5 billion in investments were announced along with 31 new Productive Development Partnerships (PDPs).
• INPI (Instituto Nacional da Propriedade Industrial)minorStrategic or Co-development Partner · 24 November 2025Formalized commitment between INPI and the Ministry of Health for a Technical Cooperation Agreement to strengthen the institutional basis for technological asset protection, analysis qualification, and essential data interchange for innovative product development.
• EBSERH (Empresa Brasileira de Serviços Hospitalares)minorStrategic or Co-development Partner · 24 November 2025Agreement between Ebserh, Ministry of Health, MDIC, ANVISA, SEBRAE, and PAHO/WHO opens new fronts for supporting health startups and technology-based companies, strengthening integration between university hospitals, clinical research environments, and entrepreneurs.
• Ministry of Health (Ministério da Saúde)coreStrategic or Co-development Partner · 3 July 2025Abiquifi participated in the signing of the decree establishing the National Program for Radical Innovation in Health. The program, with R$ 600 million in projected investments over four years, focuses on bridging the 'valley of death' between basic research and commercial product launch. Abiquifi's own Radical Innovation Program (launched in 2018) is aligned with this government initiative.
• CNPEM (Centro Nacional de Pesquisa em Energia e Materiais)coreStrategic or Co-development Partner · 3 July 2025A new Embrapii Competence Center was announced in partnership with the Ministry of Health and CNPEM, dedicated to developing Active Pharmaceutical Ingredients (APIs) from Brazil's biodiversity. This center aims to strengthen national API production capacity and technological sovereignty.
• EMBRAPII (Empresa Brasileira de Pesquisa e Inovação Industrial)coreStrategic or Co-development Partner · 3 July 2025EMBRAPII partners with Abiquifi and the Ministry of Health to establish competence centers for pharmaceutical development. The new Embrapii center at CNPEM focuses on API development from biodiversity, with Abiquifi acting as an intermediary between industry, government, and research institutions.
• ApexBrasil (Agência Brasileira de Promoção de Exportações e Investimentos)coreGTM or Marketing PartnerStrategic partnership between Abiquifi and ApexBrasil to strengthen and internationalize the Brazilian pharmaceutical industry. The Brazilian Pharma & Health (BPH) project, led by Abiquifi with ApexBrasil, promotes Brazilian companies in global markets, supports participation in international trade fairs (CPHI Worldwide, BIO Convention), organizes trade missions, and facilitates market entry for Brazilian companies. The project focuses on export development and foreign direct investment attraction.
• ANVISA (Agência Nacional de Vigilância Sanitária)coreStrategic or Co-development PartnerAbiquifi works closely with ANVISA on regulatory modernization, including the new cannabis medicinal regulatory framework (RDC 327 revision), clinical trial authorization, and regulatory predictability for innovative products. The association participates in regulatory discussions and policy formulation.
• Fiocruz (Fundação Oswaldo Cruz)coreStrategic or Co-development PartnerFiocruz is part of the Brazilian delegation at BIO Convention 2026. Bio-Manguinhos/Fiocruz is a sponsor of BIO Convention 2026. Fiocruz, in partnership with Gemma Therapeutics and Casa dos Raros, is conducting a gene therapy clinical study authorized by ANVISA.
• Sindusfarma (Sindicato da Indústria de Produtos Farmacêuticos)minorStrategic or Co-development PartnerPartnership with Sindusfarma to offer introductory courses on pricing strategies in the pharmaceutical sector, focusing on practical evaluation tools applicable to funding rounds, investment decisions, mergers and acquisitions, licensing agreements, and portfolio optimization. Sindusfarma is also a sponsor of BIO Convention 2026.
• Thermo Fisher ScientificminorGTM or Marketing PartnerThermo Fisher Scientific is an Abiquifi member and participated in the Brazilian delegation visit to their California facility during BIO Convention 2026. It is also a sponsor of BIO Convention 2026.
• Embrapii (multiple units: ESALQ, IQSint/USP, UFMG, USP-IFSC)coreStrategic or Co-development PartnerEmbrapii units (ESALQ, IQSint/USP, UFMG, USP-IFSC, CNPEM) presented their technological infrastructure and partnership possibilities for pharmaceutical development and cannabis plant cultivation during WNTC 2026. Units work collaboratively and non-competitively to support innovation.
• MAPA (Ministério da Agricultura e Pecuária)coreStrategic or Co-development PartnerAbiquifi engages with MAPA on structuring production chains for plant-based inputs, particularly medicinal cannabis cultivation. The ministry controls the first stage of cannabis production and is key to the traceability system. Abiquifi is organizing the 1st Health Innovation Seminar with MAPA in Brasília.
• MCTI (Ministério da Ciência, Tecnologia e Inovação)coreStrategic or Co-development PartnerMCTI co-leads the National Program for Radical Innovation in Health and is part of the Brazilian delegation at BIO Convention 2026. The ministry coordinates with Abiquifi on defining research priorities and launching specific funding calls for pharmaceutical innovation.

Scale indicators15 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Cefic (European Chemical Industry Council): Brussels-based umbrella for the European chemical industry, hosting sector groups like APIC and EFCG. Comparable in industry-association leadership and policy influence, but covers chemicals far beyond pharma inputs.
• PhRMA (Pharmaceutical Research and Manufacturers of America): Largest US pharma industry association. Comparable in advocacy and policy influence, but covers branded R&D-driven pharma rather than the upstream API/input niche ABIQUIFI serves.
• India Pharmaceutical Alliance: Indian pharma industry alliance covering both API and finished formulations. Comparable as an emerging-market pharma association pursuing self-sufficiency and export competitiveness, similar to ABIQUIFI's national-sovereignty narrative.

Regional players

• BPI (Bundesverband der Pharmazeutischen Industrie): German pharmaceutical industry association. Comparable industry-association structure and advocacy function, but operates in a different (developed) geography and represents finished-product manufacturers more heavily than APIs.

Direct peers

• APIC (Active Pharmaceutical Ingredients Committee, Cefic): Cefic committee specifically dedicated to API manufacturers in Europe. Direct functional peer to ABIQUIFI's focus on API producers, regulatory engagement, and supply-chain policy.
• BDMA (Bulk Drug Manufacturers Association, India): Indian trade body for bulk drug / API manufacturers. Comparable to ABIQUIFI as a national-level association supporting an emerging-market API production base competing with China on global supply.
• EFCG (European Fine Chemicals Group): European sector group representing fine chemicals and API manufacturers within Cefic. Highly comparable to ABIQUIFI in representing API producers on regulatory and policy matters at the regional level.
• IPEC (International Pharmaceutical Excipients Council): Global industry association focused on pharmaceutical excipients and inputs, with regional chapters. Directly comparable to ABIQUIFI as a pharma-inputs advocacy and standards body serving manufacturers.
• KPBMA (Korea Pharmaceutical and Bio-Pharma Manufacturers Association): Korean pharmaceutical and biopharma manufacturers association. Comparable in representing an Asian-country pharma manufacturing base and providing export-promotion and regulatory advocacy services to members.
• DCAT (Drug, Chemical & Associated Technologies Association): US-based member-driven organization for the pharmaceutical manufacturing value chain, including APIs, excipients, and chemical inputs. Closest functional analog to ABIQUIFI in scope, structure, and services (networking, intelligence, advocacy).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks4 records

Key highlights5 records

Customer concentration

• YouTubeyoutube.com/@abiquifi
• LinkedInlinkedin.com/company/abiquifi
• Instagraminstagram.com/abiquifi

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ABIQUIFI - Associação Brasileira da Indústria de Insumos Farmacêuticos